Intrathecal Kappa Free Light Chains As Markers for Multiple Sclerosis

Overview

Journal Sci Rep

Specialty Science

Date 2020 Nov 24

PMID 33230241

Citations 21

Authors

D Vecchio

G Bellomo

R Serino

E Virgilio

M Lamonaca

U Dianzani

R Cantello

C Comi

I Crespi

Affiliations

Soon will be listed here.

Abstract

Cerebrospinal fluid (CSF) kappa free light chain (KFLC) index has been described as a reliable marker of intrathecal IgG synthesis to diagnose multiple sclerosis (MS). Our aims were: (1) to compare the efficiency of KFLC through different interpretation approaches in diagnosing MS. (2) to evaluate the prognostic value of KFLC in radiologically and clinically isolated syndromes (RIS-CIS). We enrolled 133 MS patients and 240 with other neurological diseases (93 inflammatory including 18 RIS-CIS, 147 non-inflammatory). Albumin, lambda free light chain (LFLC) and KFLC were measured in the CSF and serum by nephelometry. We included two groups of markers: (a) corrected for blood-CSF barrier permeability: immunoglobulin G (IgG), KFLC and LFLC indexes. (b) CSF ratios (not including albumin and serum-correction): CSF KFLC/LFLC, CSF KFLC/IgG, CSF LFLC/IgG. KFLC were significantly higher in MS patients compared to those with other diseases (both inflammatory or not). KFLC index and CSF KFLC/IgG ratio showed high sensitivity (93% and 86.5%) and moderate specificity (85% and 88%) in diagnosing MS. RIS-CIS patients who converted to MS showed greater KFLC index and CSF KFLC/IgG. Despite OB are confirmed to be the gold-standard to detect intrathecal IgG synthesis, the KFLC confirmed their accuracy in MS diagnosis. A "kappa-oriented" response characterizes MS and has a prognostic impact in the RIS-CIS population.

Citing Articles

Biomarkers of Intrathecal Synthesis May Be Associated with Cognitive Impairment at MS Diagnosis.

Virgilio E, Ciampana V, Puricelli C, Naldi P, Bianchi A, Dianzani U Int J Mol Sci. 2025; 26(2).

PMID: 39859538 PMC: 11765557. DOI: 10.3390/ijms26020826.

Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis.

Dekeyser C, De Kesel P, Cambron M, Vanopdenbosch L, Van Hijfte L, Vercammen M Front Immunol. 2024; 15:1385231.

PMID: 38745673 PMC: 11091388. DOI: 10.3389/fimmu.2024.1385231.

Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis.

Monreal E, Fernandez-Velasco J, Garcia-Soidan A, Sainz De La Maza S, Espino M, Villarrubia N Front Immunol. 2023; 14:1288169.

PMID: 37954589 PMC: 10634415. DOI: 10.3389/fimmu.2023.1288169.

Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated Syndromes.

Levraut M, Gavoille A, Landes-Chateau C, Cohen M, Bresch S, Seitz-Polski B Neurol Neuroimmunol Neuroinflamm. 2023; 10(6).

PMID: 37640543 PMC: 10462056. DOI: 10.1212/NXI.0000000000200156.

Absence of Oligoclonal Bands in Multiple Sclerosis: A Call for Differential Diagnosis.

Katsarogiannis E, Landtblom A, Kristoffersson A, Wikstrom J, Semnic R, Berntsson S J Clin Med. 2023; 12(14).

PMID: 37510771 PMC: 10380970. DOI: 10.3390/jcm12144656.

References

Puthenparampil M, Altinier S, Stropparo E, Zywicki S, Poggiali D, Cazzola C . Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination. Mult Scler Relat Disord. 2018; 25:241-245. DOI: 10.1016/j.msard.2018.08.002. View

Kaplan B, Ganelin-Cohen E, Golderman S, Livneh A . Diagnostic utility of kappa free light chains in multiple sclerosis. Expert Rev Mol Diagn. 2019; 19(4):277-279. DOI: 10.1080/14737159.2019.1586535. View

Senel M, Tumani H, Lauda F, Presslauer S, Mojib-Yezdani R, Otto M . Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis. PLoS One. 2014; 9(4):e88680. PMC: 3973621. DOI: 10.1371/journal.pone.0088680. View

Fischer C, Arneth B, Koehler J, Lotz J, Lackner K . Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis. Clin Chem. 2004; 50(10):1809-13. DOI: 10.1373/clinchem.2004.033977. View

Crespi I, Vecchio D, Serino R, Saliva E, Virgilio E, Sulas M . K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up. J Clin Med. 2019; 8(4). PMC: 6518364. DOI: 10.3390/jcm8040446. View

Avasarala J, Cross A, Trotter J . Oligoclonal band number as a marker for prognosis in multiple sclerosis. Arch Neurol. 2001; 58(12):2044-5. DOI: 10.1001/archneur.58.12.2044. View

Polman C, Reingold S, Banwell B, Clanet M, Cohen J, Filippi M . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69(2):292-302. PMC: 3084507. DOI: 10.1002/ana.22366. View

Villar L, Espino M, Costa-Frossard L, Muriel A, Jimenez J, Alvarez-Cermeno J . High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis. Clin Chim Acta. 2012; 413(23-24):1813-6. DOI: 10.1016/j.cca.2012.07.007. View

Ramsden D . Multiple sclerosis: assay of free immunoglobulin light chains. Ann Clin Biochem. 2016; 54(1):5-13. DOI: 10.1177/0004563216652175. View

10.

Emersic A, Anadolli V, Krsnik M, Rot U . Intrathecal immunoglobulin synthesis: The potential value of an adjunct test. Clin Chim Acta. 2018; 489:109-116. DOI: 10.1016/j.cca.2018.12.006. View

11.

Schwenkenbecher P, Konen F, Wurster U, Witte T, Gingele S, Suhs K . Reiber's Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis?. Diagnostics (Basel). 2019; 9(4). PMC: 6963502. DOI: 10.3390/diagnostics9040194. View

12.

Reiber H, Zeman D, Kusnierova P, Mundwiler E, Bernasconi L . Diagnostic relevance of free light chains in cerebrospinal fluid - The hyperbolic reference range for reliable data interpretation in quotient diagrams. Clin Chim Acta. 2019; 497:153-162. DOI: 10.1016/j.cca.2019.07.027. View

13.

Rinker 2nd J, Trinkaus K, Cross A . Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis. Neurology. 2006; 67(7):1288-90. DOI: 10.1212/01.wnl.0000238107.31364.21. View

14.

Makshakov G, Nazarov V, Kochetova O, Surkova E, Lapin S, Evdoshenko E . Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis. PLoS One. 2015; 10(11):e0143375. PMC: 4659555. DOI: 10.1371/journal.pone.0143375. View

15.

Rudick R, Cookfair D, Simonian N, Ransohoff R, Richert J, Jacobs L . Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. J Neuroimmunol. 1999; 93(1-2):8-14. DOI: 10.1016/s0165-5728(98)00174-x. View

16.

Voortman M, Stojakovic T, Pirpamer L, Jehna M, Langkammer C, Scharnagl H . Prognostic value of free light chains lambda and kappa in early multiple sclerosis. Mult Scler. 2016; 23(11):1496-1505. DOI: 10.1177/1352458516681503. View

17.

Thompson A, Banwell B, Barkhof F, Carroll W, Coetzee T, Comi G . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017; 17(2):162-173. DOI: 10.1016/S1474-4422(17)30470-2. View

18.

Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J . Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. Mult Scler. 2015; 21(8):1013-24. DOI: 10.1177/1352458514568827. View

19.

Crespi I, Sulas M, Mora R, Naldi P, Vecchio D, Comi C . Combined use of Kappa Free Light Chain Index and Isoelectrofocusing of Cerebro-Spinal Fluid in Diagnosing Multiple Sclerosis: Performances and Costs. Clin Lab. 2017; 63(3):551-559. DOI: 10.7754/Clin.Lab.2016.160930. View

20.

Amato M, Ponziani G . A prospective study on the prognosis of multiple sclerosis. Neurol Sci. 2001; 21(4 Suppl 2):S831-8. DOI: 10.1007/s100720070021. View